The mechanisms by which molecular chaperones assist quality control of cytosolic proteins are poorly understood. Analysis of the chaperone requirements for degradation of misfolded variants of a cytosolic protein, the VHL tumor suppressor, reveals that distinct chaperone pathways mediate its folding and quality control. While both folding and degradation of VHL require Hsp70, the chaperonin TRiC is essential for folding but is dispensable for degradation. Conversely, the chaperone Hsp90 neither participates in VHL folding nor is required to maintain misfolded VHL solubility but is essential for its degradation. The cochaperone HOP/Sti1p also participates in VHL quality control and may direct the triage decision by bridging the Hsp70-Hsp90 interaction. Our finding that a distinct chaperone complex is uniquely required for quality control provides evidence for active and specific chaperone participation in triage decisions and suggests that a hierarchy of chaperone interactions can control the alternate fates of a cytosolic protein.
. However, these studies do not clarify the question of how chaperones contribute to the triage decision that targets polypeptides for degradation. Understanding how chaperones help select nonnative proteins for degradation has been hindered by the use of grossly misfolded or "abnormal" polypeptides as models. Given that these proteins cannot fold under any circumstance and can only either be degraded or aggregate, they are not adequate to address the mechanism of a physiological triage decision. Based on these studies, a simple model for protein quality control was proposed, whereby chaperones perform a passive "holding" function, maintaining the solubility of misfolded intermediates, thus facilitating sampling by the ubiquitination machinery (Wickner et al., 1999) . In this view, the role of chaperones in quality control is an extension of their primary role in folding, in which repeated attempts to fold a defective protein, through cycles of chaperone binding and release to the bulk solution, would eventually result in passive partitioning to the degradation machinery (Wickner et al., 1999) . A distinguishing feature of this model is that the requirement for chaperones in quality control stems primarily from the need to maintain the solubility of misfolded intermediates and is thus nonspecific. Consequently, any chaperone system capable of binding a nonnative polypeptide may assist its degradation. An alternative model, raised by recent observations that some chaperones specifically interact with components of the ubiquitin-proteasome pathway (Verma et al., 2000; Cyr et al., 2002) , envisions that certain cellular chaperones play an active and specific role in selecting a polypeptide for cytosolic quality control (McClellan and Frydman, 2001 ). Accordingly, inactivation of these particular chaperones should compromise the degradation of misfolded proteins.
Here we sought to distinguish between a passive, nonspecific model of chaperone action and an active and specific role for chaperones in cytosolic quality control. To this end, we studied the chaperone requirements for the degradation of a physiologically relevant substrate of the quality-control machinery. Unlike previously studied model substrates for cytosolic quality control, the chaperone-mediated folding pathway of the von Hippel-Lindau (VHL) tumor-suppressor protein is well characterized (Feldman et (Schoenfeld et al., 2000) .
In this study we establish that the chaperone systems required for VHL degradation are different from those required for its folding. While the chaperonin TRiC/CCT is required for VHL folding, it is dispensable for degradation. In contrast, Hsp90 is not required for VHL folding but is specifically essential for its degradation. Our findings are inconsistent with proposed models for cytosolic quality control whereby the same chaperones that promote folding of a polypeptide will also facilitate its passive partitioning to the degradation machinery. Because VHL is still soluble and associated with chaperones, including Hsp70 and TRiC, in Hsp90-deficient cells where degradation is prevented, it appears that the role of chaperones in quality control is not limited to passively maintaining solubility of misfolded intermediates. Instead, it appears that only some cellular chaperones can target misfolded VHL for degradation, supporting the idea that specific, rather than stochastic, chaperone pathways act in folding and degradation. The identification of two distinct pathways of chaperone interactions for VHL, one leading to folding and one to degradation, indicates that the fate of a cytosolic protein may be controlled by a hierarchy of chaperone interactions. These findings provide novel insights into the logic underlying triage decisions in the eukaryotic cytosol. homolog Elc1p, which can bind in vitro to VHL-derived peptides (Botuyan et al., 1999). This is not the case, however, as deletion of ELC1 did not alter the rate of wt VHL degradation (Delc1; Figure 1B) . The difference in half-life may instead arise from conformational differences between these misfolded VHL variants.
Results

Misfolded
We next examined the role of the ubiquitin-proteasome pathway in VHL degradation. Both misfolded VHL variants were stabilized in the proteasome mutant strains cim3-1 and pre1-1 ( Figure 1A , right-hand panels and data not shown). Furthermore, VHL was also stabilized by the deletion of specific ubiquitin-conjugating enzymes (UBCs or E2s, Figure 1C ), indicating that VHL degradation is ubiquitin dependent. While L158P VHL was strongly stabilized in cells lacking the functionally redundant UBC4 and UBC5 E2s ( Figure 1C) , full stabilization of wt VHL required the additional deletion of the E2 pair UBC6/UBC7 ( Figure 1C ). This discrepancy further suggests that conformational differences between these VHL variants may influence their ubiquitination pathway. Interestingly, UBC4/UBC5 and UBC6/UBC7 were previously implicated in the degradation of other misfolded proteins (Hampton, 2002; Seufert and Jentsch, 1990 ). Altogether, these data establish that in yeast, as in mammalian cells (Schoenfeld et al., 2000) , misfolded One notable difference between the SSA and SSB Hsp70 classes is that SSAs contain a C-terminal motif, EEVD, which mediates interaction with tetratricopeptide (TPR) domain-containing proteins (Scheufler et al., 2000) . Strikingly, the degradation of both misfolded VHL variants was markedly inhibited in cells lacking the TPR-containing Ssap cofactor STI1 ( Figure 3A , bottom panel; Figure S6Aiv ).
Successful partitioning to the ubiquitination and degradation machinery requires that the polypeptide remain soluble. We therefore examined whether deletion of STI1 blocks degradation by failing to prevent aggregation of misfolded VHL. In wt cells, most of the VHL protein was soluble and remained in the supernatant (Sn) of a high-speed centrifugation, with only a small fraction found in the insoluble pellet (Pel; Figure 3B ). Importantly, no change in the solubility of VHL was observed in cells lacking Sti1p ( Figure 3B ). Because VHL remains soluble in the absence of Sti1p yet fails to be degraded, we conclude that the function of Sti1p in (Figure S4) . We conclude that the stabilization of VHL in hsp82 G170D cells is not due to a general defect in proteasome-mediated degradation. Intriguingly, degradation of nonnative Tub3p, also a chaperonin substrate, was partially compromised in hsp82 G170D cells at 37°C, suggesting that Hsp90 may play a role in quality control of other nonnative proteins (see also Discussion and Figure S7 ).
The requirement for Hsp90 in VHL degradation may in principle reflect a previously undescribed role for Hsp90 in VHL folding, which is coupled to assembly of the VBC complex (Feldman et Our findings that Hsp90 is dispensable for VHL folding, but required for VHL degradation, were confirmed by analysis of these processes in mammalian cells (Figures 4C and 4D) . VBC assembly was analyzed in HEK cells as previously described (Feldman et 
Discussion
A major unexplored question in cell biology is how the cell selects misfolded cytosolic proteins and targets them for elimination. Triage decisions must balance the need to protect nonnative newly translated proteins that have not yet reached their fully folded state with the requirement to prevent the accumulation of aggregation-prone toxic species. Here we investigated how the cellular chaperone machinery participates in quality control of a physiologically relevant misfolded cytosolic protein. The availability of folding-defective variants of a cellular protein with a well-characterized chaperonedependent folding pathway, the VHL tumor suppressor, allowed us to distinguish between possible models for chaperone function in quality control. Previous studies using artificial or damaged substrates that were either grossly misfolded and aggregation prone or poorly characterized with regard to their chaperone interactions led to a model whereby chaperones play a passive, nonspecific holding function in degradation, merely maintaining nonnative polypeptides in a soluble state. A more complex role for chaperones in cytosolic quality control emerges from our in vivo analysis of misfolded VHL degradation, which indicates that specific, rather than stochastic, chaperone pathways govern its folding and degradation (Figure 6 ). Of the two chaperones required for VHL folding, TRiC/CCT and Hsp70 (Ssa1p), only Ssa1p is required for degradation, while TRiC/ CCT function is dispensable (Figure 2) . Strikingly, VHL degradation specifically requires another chaperone, Hsp90, which does not participate in VHL folding (Figure 4) . Importantly, VHL stabilization in Hsp90-or Sti1-deficient cells is not caused by aggregation ( Figure 3B and data not shown) but rather results from the loss of specific chaperone interactions with Hsp90 and a subset of Hsp90 cofactors. Since VHL is still soluble and associated with chaperones, including Hsp70 and TRiC, in Dsti1 or Hsp90-deficient cells where degradation is prevented, we conclude that binding to TRiC or Hsp70 does not suffice to target misfolded VHL for degradation. Furthermore, because loss of Hsp90 func- tion blocks VHL degradation, our data indicate that Hsp90 is not merely engaging VHL in a futile folding cycle but is actually actively required for degradation. These findings are inconsistent with proposed models for cytosolic quality control whereby chaperones function only to maintain polypeptide solubility and passively facilitate partitioning to the degradation machinery. Instead, it appears that certain chaperones play an active and specific role in the triage process.
The specific requirement for Hsp90 in the degradation of a protein that is not one of its folding clients is surprising. Our data suggest that early Hsp90 complexes not only are intermediates leading to formation of late Hsp90 complexes during client-protein folding but may also have an independent function in quality control. Accordingly, we propose that Figure S7 ). Since the pulse-chase experiment looks at the degradation of all rapidly turned-over polypeptides, whether or not they are found in the ER, mitochondria, or the cytoplasm, the fraction of cytosolic proteins stabilized in the Hsp90 mutants may be higher than this rough analysis indicates. Thus, Hsp90 is important for the degradation of a significant fraction of, but not all, misfolded polypeptides. It is likely that cells contain several chaperone pathways leading to the degradation of distinct classes of misfolded proteins, similar to what is observed for chaperone-mediated protein folding, where different chaperone pathways mediate the folding of different classes of proteins. This might be expected, given the critical importance of ensuring efficient protein quality control for cell viability and the fact that, upon misfolding, different structural classes of proteins may require distinct cellular components for efficient recognition and elimination. An important question for future studies will be to define the spectrum of proteins that require Hsp90 for quality control.
Our analysis of the chaperone pathways required for folding and quality control of the VHL tumor suppressor provides novel insights into the logic underlying triage decisions in the eukaryotic cytosol. The identification of two distinct pathways of chaperone interactions for VHL (Figure 6 ), one leading to folding and one to degradation, suggests that the fate of a given cytosolic protein may be controlled by a hierarchy of chaperone in-teractions. In the case of VHL, cotranslational coupling mechanisms may establish an initial association with TRiC (Thulasiraman et al., 1999) , resulting in a chaperone hierarchy that favors folding over degradation. However, failure to fold may allow subsequent association with the Hsp90 complex, leading to degradation. Consistent with this model, we find that the tcp1-2 mutation, which destabilizes the TRiC complex, resulting in substrate binding defects (Camasses et al., 2003) , slightly enhances the degradation rate of VHL ( Figure  2B) , suggesting that the folding and degradation pathways may be in a dynamic equilibrium. In principle, the fate of newly translated VHL may be governed by the affinity and binding kinetics of its folding intermediates to the chaperone systems in each pathway. Of note, Hsp90 has been proposed to recognize structured folding intermediates (Picard, 2002 ura3-1 leu2-3,12 his3-11,15 trp1-1 can1- Cell Culture and Transfection HEK293 cells cultured in DMEM/5% FCS (Gibco) were transfected with 8-10 g of plasmid DNA using calcium phosphate as described (Feldman et al., 2003) .
Mammalian expression plasmids for wt VHL, L158P VHL, elongin B, and elongin C were described previously (Feldman et al., 2003) .
Additional Reagents
The Hsp90-inhibiting ansamycins macbecin II and geldanamycin (GA) were obtained from the NCI Drug Synthesis and Chemistry Branch and were solubilized in DMSO (Sigma) prior to use. 
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